Abstract:Background and aims:<bold> </bold>Dynamic evaluation of critically ill patients is the key to predicting their outcomes. Most scores based on the Model for End-stage Liver Disease (MELD) and acute-on-chronic liver failure (ACLF) utilize point-in-time assessment. This study mainly aimed to investigate the impact of dynamic clinical course change on post-liver transplantation (LT) survival.Methods:<bold> </bold>This study included 637 adults (overall cohort) with benign end-stage liver diseases. The authors compared the MELD scores and our ACLF-based dynamic evaluation scores. Patients enrolled or transplanted with ACLF-3 were defined as the ACLF-3 cohort ( n =158). The primary outcome was 1-year mortality. Delta MELD and Delta CLIF-OF (Chronic Liver Failure-Organ Failure) represented the respective dynamic changes in liver transplant function. Discrimination was assessed using the area under the curve. A Cox regression analysis identified independent risk factors for specific organ failure and 1-year mortality.Results:<bold> </bold>Patients were grouped into three groups: the deterioration group (D), the stable group (S), and the improvement group (I). The deterioration group (Delta CLIF-OF >= 2) was more likely to receive national liver allocation ( P =0.012) but experienced longer cold ischemia time ( P =0.006) than other groups. The area under the curves for Delta CLIF-OF were 0.752 for the entire cohort and 0.767 for ACLF-3 cohorts, both superior to Delta MELD ( P <0.001 for both). Compared to the improvement group, the 1-year mortality hazard ratios (HR) of the deterioration group were 12.57 (6.72-23.48) for the overall cohort and 7.00 (3.73-13.09) for the ACLF-3 cohort. Extrahepatic organs subscore change (HR=1.783 (1.266-2.512) for neurologic; 1.653 (1.205-2.269) for circulation; 1.906 (1.324-2.743) for respiration; 1.473 (1.097-1.976) for renal) were key to transplantation outcomes in the ACLF-3 cohort. CLIF-OF at LT (HR=1.193), Delta CLIF-OF (HR=1.354), and cold ischemia time (HR=1.077) were independent risk factors of mortality for the overall cohort, while Delta CLIF-OF (HR=1.384) was the only independent risk factor for the ACLF-3 cohort. Non-ACLF-3 patients showed a higher survival rate than patients with ACLF-3 in all groups ( P =0.002 for I, P =0.005 for S, and P =0.001 for D).Conclusion:<bold> </bold>This was the first ACLF-based dynamic evaluation study. Delta CLIF-OF was a more powerful predictor of post-LT mortality than Delta MELD. Extrahepatic organ failures were core risk factors for ACLF-3 patients. CLIF-OF at LT, Delta CLIF-OF, and cold ischemia time were independent risk factors for post-LT mortality. Patients with a worse baseline condition and a deteriorating clinical course had the worst prognosis. Dynamic evaluation was important in risk stratification and recipient selection.

Etiology-Specific Effects of Impaired Functional Status on Liver Transplant Outcomes

Association of Karnofsky Performance Status with liver transplant outcomes in hepatocellular carcinoma

Short-term and long-term outcomes of liver transplantation using moderately and severely steatotic donor livers: A systematic review.

Extrahepatic organs in the development of non-alcoholic fatty liver disease in liver transplant patients

Role of the Immune System in Liver Transplantation and Its Implications for Therapeutic Interventions

Impact of Functional Status at the Time of Transplant on Short-Term Pediatric Lung Transplant Outcomes in the USA

End-Stage Liver Disease Comorbidities in Patients Awaiting Transplantation: Identification and Impact on Liver Transplant Survival

The Influence of Liver Dysfunction Before Transplantation and During Conditioning Period on the Outcome of Allogeneic Hematopoietic Stem Cell Transplantation

Recipient functional status impacts on short and long-term intestinal transplant outcomes in United States adults

Racial and ethnic disparities in post-liver transplant outcomes for patients with acute-on-chronic liver failure: An analysis of the UNOS database

Therapeutic Effectiveness of Liver Transplantation: a Single Center Study of 203 Consecutive Cases

Short- and Long-Term Outcomes for Ethnic Minorities in the United States After Liver Transplantation: Parsing the Hispanic Paradox

Metabolic Complications in Liver Transplantation Recipients: How We Can Optimize Long‐Term Survival

Waitlist and transplant outcomes in patients with metabolic dysfunction-associated steatotic liver disease and autoimmune hepatitis

Impact of cirrhosis-related complications on posttransplant survival in patients with acute-on-chronic liver failure

Dynamic evaluation based on acute-on-chronic liver failure predicts survival of patients after liver transplantation: a cohort study

Impact of Inflammatory Bowel Disease Subtypes on the Post-liver Transplant Outcomes of Patients with Primary Sclerosing Cholangitis

Stratified Analysis of Survival Benefit for ABO-incompatible Deceased-donor Liver Transplantation: Multicenter Propensity Score-matched Study

[Therapeutic Effect of Liver Transplantation on Acute Liver Failure].

Which recipient pretransplant factors, such as MELD, renal function, sarcopenia, and recent sepsis influence suitability for and outcome after living donor liver transplantation? A systematic review of the literature and expert panel recommendations

Disparities in Liver Transplant Outcomes: Race/Ethnicity and Individual- and Neighborhood-Level Socioeconomic Status